Ohio Medical Marijuana in High Demand With Half-Million Dollars in Sales

PRESS RELEASE – The European Food Safety Authority (EFSA) recently changed guidance on cannabinoids, asserting that all food products using any cannabinoid should now have special authorization under EU “novel food ingredient” regulation.

The UK, even while it remains in the EU, does not have to follow that proposal–EFSA guidance is non-binding and down to member states to implement.

But countries typically follow EFSA’s lead when creating national legislation, and some have already started taking enforcement action on CBD products. And the UK’s Food Standards Agency has told CBD-Intel that it fully intends to enforce the guidance–no matter whether the UK is in the EU.

Under the new proposal, CBD, full-spectrum extracts and any other food product using a cannabinoid as an ingredient could be targeted.

The new guidance now states that: “Derived products containing cannabinoids are considered novel foods as a history of consumption has not been demonstrated.”

The guidance further clarifies

... read more at: http://www.cannabisbusinesstimes.com/ohio-medical-marijuana-half-million-dollars-in-sales.aspx